BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10705020)

  • 1. A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05).
    Roos DE; O'Brien PC; Smith JG; Spry NA; Hoskin PJ; Burmeister BH; Turner SL; Bernshaw DM
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):975-81. PubMed ID: 10705020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).
    Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL;
    Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05).
    Roos DE; Davis SR; Turner SL; O'Brien PC; Spry NA; Burmeister BH; Hoskin PJ; Ball DL
    Radiother Oncol; 2003 May; 67(2):207-12. PubMed ID: 12812852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for neuropathic pain due to bone metastases.
    Roos DE
    Ann Palliat Med; 2015 Oct; 4(4):220-4. PubMed ID: 26541402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.
    Chow E; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JS; Brundage MD; Nabid A; Tissing-Tan CJ; Oei B; Babington S; Demas WF; Wilson CF; Meyer RM; Chen BE; Wong RK
    Lancet Oncol; 2014 Feb; 15(2):164-71. PubMed ID: 24369114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain.
    Pollicino CA; Turner SL; Roos DE; O'Brien PC
    Radiother Oncol; 2005 Sep; 76(3):264-9. PubMed ID: 16153729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility audits for the randomized neuropathic bone pain trial (TROG 96.05).
    Roos DE; Davis SR; O'Brien PC; Hoskin PJ; Spry NA; Burmeister BH; Turner SL; Bernshaw DM
    Australas Radiol; 2000 Aug; 44(3):303-7. PubMed ID: 10974724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
    Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
    J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.
    Kaasa S; Brenne E; Lund JA; Fayers P; Falkmer U; Holmberg M; Lagerlund M; Bruland O
    Radiother Oncol; 2006 Jun; 79(3):278-84. PubMed ID: 16793154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.
    Wu JS; Wong R; Johnston M; Bezjak A; Whelan T;
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):594-605. PubMed ID: 12573746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose radiotherapy (6 Gy): palliation in painful bone metastases.
    Uppelschoten JM; Wanders SL; de Jong JM
    Radiother Oncol; 1995 Sep; 36(3):198-202. PubMed ID: 8532906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.
    Sze WM; Shelley MD; Held I; Wilt TJ; Mason MD
    Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):345-52. PubMed ID: 14524489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of practice in palliative radiotherapy for painful bone metastases: a survey in Japan.
    Nakamura N; Shikama N; Wada H; Harada H; Nozaki M; Nagakura H; Tago M; Oguchi M; Uchida N;
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e117-20. PubMed ID: 22381902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials.
    Sze WM; Shelley M; Held I; Mason M
    Cochrane Database Syst Rev; 2004; 2002(2):CD004721. PubMed ID: 15106258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiosensitivity of bone metastases from tumors in different primary sites].
    Khmelevsky EV; Bychkova NM
    Vopr Onkol; 2015; 61(1):77-84. PubMed ID: 26016150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.
    Radiother Oncol; 1999 Aug; 52(2):111-21. PubMed ID: 10577696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases.
    Nielsen OS; Bentzen SM; Sandberg E; Gadeberg CC; Timothy AR
    Radiother Oncol; 1998 Jun; 47(3):233-40. PubMed ID: 9681885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
    Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?
    Fairchild A; Barnes E; Ghosh S; Ben-Josef E; Roos D; Hartsell W; Holt T; Wu J; Janjan N; Chow E
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1501-10. PubMed ID: 19464820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA).
    Salazar OM; Sandhu T; da Motta NW; Escutia MA; Lanzós-Gonzales E; Mouelle-Sone A; Moscol A; Zaharia M; Zaman S
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):765-75. PubMed ID: 11395246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.